Don’t overlook the costs of medication and equipment

I agree with the principle espoused in the report “S’poreans, providers have role in keeping health costs down: Gan” (July 10). However, while the focus has been on insurance costs, we should not overlook the costs of medication and equipment.

While the Ministry of Health has been prudent by using generic medication as much as possible, there is a wide range of non-generic medications in the market, and some of the costs are driving some Singaporeans to buy from other countries that offer cheaper prices.

For example, because of the knock-on effect from the costs of non-generic medication, Thailand has curbed excessive patenting of pharmaceutical drugs, despite protests from certain companies, to bring critical but affordable medication to its population.

And recently, China has clamped down on corruption by such firms, which need not have been solely in the form of cash but also in kind, such as paid holidays for family members to accompany participants of medical conferences.

While Singapore values its patent commitments, the Health Ministry could get the best value for its supplies through leverage and close scrutiny.

As for corruption, while no cases have surfaced yet, the authorities should be mindful that it is not impossible in the world of business.